| Mrs Pamela Philbrook Leary, MA, MS, LCPC-C | |
|
1120 Center St, Suite 308, Auburn, ME 04210-6528 | |
| (207) 333-3375 | |
| (207) 333-3380 |
| Full Name | Mrs Pamela Philbrook Leary |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1120 Center St, Auburn, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528359338 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | XL3768 (Maine) | Primary |
| Entity Name | Health Affiliates Maine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932413556 PECOS PAC ID: 1951594076 Enrollment ID: O20101021000912 |
News Archive
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled "POU5-F1 Expression in Human Mesenchymal Stem Cells" and the development of new technology related to generation of human induced pluripotent stem cells (iPS).
A study has revealed that the most common screening tool used to detect autism among toddlers could be less than accurate.
A new test can be used to identify low-risk thyroid nodules, reducing unnecessary surgeries for people with thyroid nodules that have indeterminate results after biopsy. The results of the multi-center trial, which includes researchers from the Perelman School of Medicine at the University of Pennsylvania, appear online in the New England Journal of Medicine.
In a promising development for cancer patients in New Jersey and surrounding areas, the John Theurer Cancer Center at Hackensack University Medical Center announced today that it will be the first cancer center in New Jersey to acquire an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy known as the TrueBeam- system.
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela Philbrook Leary, MA, MS, LCPC-C 1120 Center St, Suite 308, Auburn, ME 04210-6528 Ph: (207) 333-3375 | Mrs Pamela Philbrook Leary, MA, MS, LCPC-C 1120 Center St, Suite 308, Auburn, ME 04210-6528 Ph: (207) 333-3375 |
News Archive
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled "POU5-F1 Expression in Human Mesenchymal Stem Cells" and the development of new technology related to generation of human induced pluripotent stem cells (iPS).
A study has revealed that the most common screening tool used to detect autism among toddlers could be less than accurate.
A new test can be used to identify low-risk thyroid nodules, reducing unnecessary surgeries for people with thyroid nodules that have indeterminate results after biopsy. The results of the multi-center trial, which includes researchers from the Perelman School of Medicine at the University of Pennsylvania, appear online in the New England Journal of Medicine.
In a promising development for cancer patients in New Jersey and surrounding areas, the John Theurer Cancer Center at Hackensack University Medical Center announced today that it will be the first cancer center in New Jersey to acquire an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy known as the TrueBeam- system.
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
› Verified 4 days ago
Wanda Sprague, Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 Court St, Auburn, ME 04210 Phone: 207-786-4498 | |
Bethany Joan Perez-febles, LCPC-CC Counselor Medicare: Not Enrolled in Medicare Practice Location: 80 Lake St, Auburn, ME 04210 Phone: 207-786-4498 Fax: 207-783-9949 | |
Jaime S Tomlinson, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 50 Chicoine Ave, Auburn, ME 04210 Phone: 207-753-0253 | |
Mr. Richard Francis Bevins, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 112 Gamage Ave, Auburn, ME 04210 Phone: 207-782-3194 Fax: 866-214-6956 | |
Mr. John P Carroll, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 336 Center St, Auburn, ME 04210 Phone: 207-783-2617 | |
Mrs. Michelle K Murley, LCSW, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 16 Western Ave, Auburn, ME 04210 Phone: 207-671-8904 | |
Cole Jospeh Quirion, MS, LCPC-C Counselor Medicare: Not Enrolled in Medicare Practice Location: 24 Falcon Dr, Auburn, ME 04210 Phone: 207-333-3382 |